BlackRock Institutional Trust’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
BFA
RSCM
EAM
CS
BlackRock Institutional Trust's TTPH Position: Q4 2016 in Review
BlackRock Institutional Trust held its Tetraphase Pharmaceuticals, Inc. (TTPH) position steady in Q4 2016 at 44,955 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2839.
BlackRock Institutional Trust first reported a position in TTPH in Q2 2013 and has held it in 15 quarters since. The position peaked at $36.1M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.
- BlackRock Institutional Trust held 44,955 shares of Tetraphase Pharmaceuticals, Inc. worth $3.62M as of Q4 2016.
- BlackRock Institutional Trust left its Tetraphase Pharmaceuticals, Inc. share count unchanged in Q4 2016.
- Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2839 holding.
- BlackRock Institutional Trust first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Tetraphase Pharmaceuticals, Inc. position peaked at $36.1M in Q2 2015.
- 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.